Chemed Corporation (NYSE:CHE) Stock Position Decreased by Riverbridge Partners LLC

Riverbridge Partners LLC cut its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 8.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,519 shares of the company's stock after selling 6,838 shares during the period. Riverbridge Partners LLC owned 0.49% of Chemed worth $44,007,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Neuberger Berman Group LLC raised its stake in shares of Chemed by 1.2% during the 4th quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company's stock worth $265,726,000 after purchasing an additional 5,809 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Chemed by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock worth $180,654,000 after purchasing an additional 4,966 shares in the last quarter. FMR LLC raised its stake in shares of Chemed by 18.9% during the 4th quarter. FMR LLC now owns 283,790 shares of the company's stock worth $150,352,000 after purchasing an additional 45,174 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Chemed by 8.2% during the 4th quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock worth $141,343,000 after purchasing an additional 20,310 shares in the last quarter. Finally, Epoch Investment Partners Inc. raised its stake in shares of Chemed by 5.1% during the 4th quarter. Epoch Investment Partners Inc. now owns 252,237 shares of the company's stock worth $133,635,000 after purchasing an additional 12,167 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CHE has been the topic of a number of recent analyst reports. Royal Bank Of Canada raised their price objective on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Stock Performance

Shares of CHE stock opened at $546.00 on Friday. The stock's 50 day simple moving average is $568.51 and its 200 day simple moving average is $564.94. Chemed Corporation has a twelve month low of $512.12 and a twelve month high of $623.61. The company has a market capitalization of $7.99 billion, a price-to-earnings ratio of 26.60, a PEG ratio of 2.27 and a beta of 0.54.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. The business had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The firm's revenue was up 9.8% compared to the same quarter last year. During the same period last year, the business earned $5.20 EPS. On average, analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.37%. The ex-dividend date of this dividend was Thursday, May 29th. Chemed's dividend payout ratio is currently 9.74%.

Insiders Place Their Bets

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of Chemed stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total value of $866,790.00. Following the transaction, the executive vice president now directly owns 16,127 shares of the company's stock, valued at $9,319,148.22. The trade was a 8.51% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. This represents a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,500 shares of company stock valued at $3,213,780 in the last three months. Company insiders own 3.29% of the company's stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.